Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Amable, Paola Romina ^a   Teixeira, Marcus Vinicius Telles ^a,b   Carias, Rosana Bizon Vieira ^a,b   Granjeiro, José Mauro ^b   Borojevic, Radovan ^a,b  

^a Excellion Biomedical Services   (Brazil)

^b INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CULTURE MEDIUM; MEMBRANE ANTIGEN;

ADIPOGENESIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; PROTEIN SYNTHESIS; THROMBOCYTE RICH PLASMA;

ADIPOGENESIS; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PLATELET-RICH PLASMA; PROTEIN BIOSYNTHESIS;

EID: 84905824551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104662     Document Type: Article

References (29)

1. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6: 230-247.
2. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16: 557-564.
3. Wang S, Qu X, Zhao RC (2012) Clinical applications of mesenchymal stem cells. J Hematol Oncol 5: 19.
4. Spees JL, Gregory CA, Singh H, Tucker HA, Peister A, et al. (2004) Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9: 747-756. (Pubitemid 38660428)
5. Ikebe C, Suzuki K (2014) Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols. Biomed Res Int 2014: 951512.
6. Heng BC, Cowan CM, Basu S (2009) Comparison of Enzymatic and Non-Enzymatic Means of Dissociating Adherent Monolayers of Mesenchymal Stem Cells. Biol Proced Online 11: 161-169.
7. Carvalho PP, Wu X, Yu G, Dietrich M, Dias IR, et al. (2011) Use of animal protein-free products for passaging adherent human adipose-derived stromal/stem cells. Cytotherapy 13: 594-597.
8. Rajala K, Lindroos B, Hussein SM, Lappalainen RS, Pekkanen-Mattila M, et al. (2010) A Defined and Xeno-Free Culture Method Enabling the Establishment of Clinical-Grade Human Embryonic, Induced Pluripotent and Adipose Stem Cells. PLoS ONE 5: e10246.
9. Hatlapatka T, Moretti P, Lavrentieva A, Hass R, Marquardt N, et al. (2011). Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions. Tissue Eng Part C Methods 17: 485-493.
10. Amable PR, Carias RBV, Teixeira MVT, Pacheco IC, Amaral RJFC, et al. (2013). Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 4: 67.
11. Amable PR, Teixeira MVT, Carias RBV, Granjeiro JM, Borojevic R (2013). Identification of appropriate reference genes for human mesenchymal cells during expansion and differentiation. PLoS One, 8: e73792.
12. Cho HS, Song IH, Park SY, Sung MC, Ahn MW, et al. (2011) Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med 31: 212-218.
13. Bernardo ME, Avanzini MA, Perotti C, Cometa AM, Moretta A, et al. (2007) Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 211: 121-130. (Pubitemid 46363901)
14. Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, et al. (2012). Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 3: 6.
15. Amable PR, Teixeira MVT, Carias RBV, Granjeiro JM, Borojevic R (2014) Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's Jelly. Stem Cell Res & Ther 5: 53.
16. Hasebe Y, Hasegawa S, Hashimoto N, Toyoda M, Matsumoto K, et al. (2011) Analysis of cell characterization using cell surface markers in the dermis. J Dermatol Sci 62: 98-106.
17. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, et al. (2010) In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28: 788-798.
18. Verrier S, Meury TR, Kupcsik L, Heini P, Stoll T, et al. (2010) Platelet-released supernatant induces osteoblastic differentiation of human mesenchymal stem cells: potential role of BMP-2. Eur Cell Mater 20: 403-414.
19. Niemeyer P, Fechner K, Milz S, Richter W, Suedkamp NP, et al. (2010) Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 31: 3572-3569.
20. Pochampally RR, Smith JR, Ylostalo J, Prockop DJ (2004) Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103: 1647-1652. (Pubitemid 38268955)
21. Roche S, Richard MJ, Favrot MC (2007) Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J Cell Biochem 101: 271-280. (Pubitemid 46698863)
22. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, et al. (2003) Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287: 98-105. (Pubitemid 36683205)
23. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, et al. (2003) Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17: 1146-1149. (Pubitemid 36722246)
24. Noël D, Caton D, Roche S, Bony C, Lehmann S, et al. (2008) Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 14: 1575-1584.
25. Spreafico A, Chellini F, Frediani B, Bernardini G, Niccolini S, et al. (2009) Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 108: 1153-1165.
26. Browning SR, Weiser AM, Woolf N, Golish R, SanGiovanni TP, et al. (2012) Platelet-Rich Plasma Increases Matrix Metalloproteinases in Cultures of Human Synovial Fibroblasts. J Bone Joint Surg Am 94: 1-7.
27. Haleem AM, Singergy AA, Sabry D, Atta HM, Rashed LA, et al. (2010) The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results. Cartilage 1: 253-261.
28. Trouillas M, Prat M, Doucet C, Ernou I, Laplace-Builhé C, et al. (2013) A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice. Stem Cell Res Ther 4: 1.
29. Xie X, Wang Y, Zhao C, Guo S, Liu S, et al. (2012) Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials 33: 7008-7018.